🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

KRKA, d.d., Novo mesto — Licensed Medicines

361 medicines held by KRKA, d.d., Novo mesto on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 361 products held by KRKA, d.d., Novo mesto
MedicineActive substanceLicence holderStatus
Abiraterone Krka 500 mg film-coated tablets
EU/1/21/1553/001-003
Abiraterone acetate KRKA, d.d., Novo mesto
Alprazolam Krka 1 mg tablets
PA1347/097/003
Alprazolam KRKA, d.d., Novo mesto Marketed
Alprazolam Krka 250 microgram tablets
PA1347/097/001
Alprazolam KRKA, d.d., Novo mesto Marketed
Alprazolam Krka 500 microgram tablets
PA1347/097/002
Alprazolam KRKA, d.d., Novo mesto Marketed
Amlodipine Krka 10 mg Tablets
PA1347/034/002
Amlodipine KRKA, d.d., Novo mesto Marketed
Amlodipine Krka 5 mg Tablets
PA1347/034/001
Amlodipine KRKA, d.d., Novo mesto Marketed
Amlodipine/Valsartan Krka 10 mg/160 mg film-coated tablets
PA1347/055/003
Amlodipine, Valsartan KRKA, d.d., Novo mesto Marketed
Amlodipine/Valsartan Krka 10 mg/320 mg film-coated tablets
PA1347/055/005
Amlodipine, Valsartan KRKA, d.d., Novo mesto Not marketed
Amlodipine/Valsartan Krka 5 mg/ 160 mg film-coated tablets
PA1347/055/002
Amlodipine, Valsartan KRKA, d.d., Novo mesto Marketed
Amlodipine/Valsartan Krka 5 mg/ 80 mg film-coated tablets
PA1347/055/001
Amlodipine, Valsartan KRKA, d.d., Novo mesto Marketed
Amlodipine/Valsartan Krka 5 mg/320 mg film-coated tablets
PA1347/055/004
Amlodipine, Valsartan KRKA, d.d., Novo mesto Not marketed
Amlodipine/Valsartan/Hydrochlorothiazide Krka 10 mg/160 mg/12.5 mg film-coated tablets
PA1347/106/002
Amlodipine, Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Amlodipine/Valsartan/Hydrochlorothiazide Krka 5 mg/160 mg/12.5 mg film-coated tablets
PA1347/106/001
Amlodipine, Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Amlodipine/Valsartan/Hydrochlorothiazide Krka 5 mg/160 mg/25 mg film-coated tablets
PA1347/106/003
Amlodipine, Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Amoxicillin/clavulanic acid Krka 500 mg/125 mg Film-Coated Tablets
PA1347/044/001
Amoxicillin, Clavulanic acid KRKA, d.d., Novo mesto Not marketed
Apeneta 100 mg prolonged-release tablets
PA1347/105/002
Tapentadol maleate hemihydrate KRKA, d.d., Novo mesto Marketed
Apeneta 150 mg prolonged-release tablets
PA1347/105/003
Tapentadol maleate hemihydrate KRKA, d.d., Novo mesto Marketed
Apeneta 200 mg prolonged-release tablets
PA1347/105/004
Tapentadol maleate hemihydrate KRKA, d.d., Novo mesto Marketed
Apeneta 250 mg prolonged-release tablets
PA1347/105/005
Tapentadol maleate hemihydrate KRKA, d.d., Novo mesto Marketed
Apeneta 50 mg prolonged-release tablets
PA1347/105/001
Tapentadol maleate hemihydrate KRKA, d.d., Novo mesto Marketed
Apixaban Krka 2.5 mg film-coated tablets
PA1347/107/001
Apixaban KRKA, d.d., Novo mesto Not marketed
Apixaban Krka 5 mg film-coated tablets
PA1347/107/002
Apixaban KRKA, d.d., Novo mesto Not marketed
Apremilast Krka 10 mg film-coated tablets Apremilast Krka 20 mg film-coated tablets Apremilast Krka 30 mg film-coated tablets
PA1347/114/001
Apremilast, Apremilast, Apremilast KRKA, d.d., Novo mesto Not marketed
Apremilast Krka 30 mg film-coated tablets
PA1347/114/002
Apremilast KRKA, d.d., Novo mesto Marketed
Aripiprazole Krka 10mg Tablets
PA1347/089/002
Aripiprazole KRKA, d.d., Novo mesto Marketed
Aripiprazole Krka 15mg Tablets
PA1347/089/003
Aripiprazole KRKA, d.d., Novo mesto Marketed
Aripiprazole Krka 30mg Tablets
PA1347/089/004
Aripiprazole KRKA, d.d., Novo mesto Marketed
Aripiprazole Krka 5mg Tablets
PA1347/089/001
Aripiprazole KRKA, d.d., Novo mesto Marketed
Aspirin Krka 75 mg gastro-resistant tablets
PA1347/070/001
Acetylsalicylic acid KRKA, d.d., Novo mesto Marketed
Atorvastatin Krka 10 mg film-coated tablets
PA1347/023/001
Atorvastatin KRKA, d.d., Novo mesto Marketed
Atorvastatin Krka 20 mg film-coated tablets
PA1347/023/002
Atorvastatin KRKA, d.d., Novo mesto Marketed
Atorvastatin Krka 40 mg film-coated tablets
PA1347/023/003
Atorvastatin KRKA, d.d., Novo mesto Marketed
Atorvastatin Krka 80 mg film-coated tablets
PA1347/009/004
Atorvastatin KRKA, d.d., Novo mesto Marketed
Azithromycin Krka 250 mg film-coated tablets
PA1347/047/001
Azithromycin KRKA, d.d., Novo mesto Not marketed
Bisoprolol Krka 10 mg film-coated tablets
PA1347/031/003
BISOPROLOL FUMARATE KRKA, d.d., Novo mesto Marketed
Bisoprolol Krka 2.5 mg film-coated tablets
PA1347/031/001
BISOPROLOL FUMARATE KRKA, d.d., Novo mesto Marketed
Bisoprolol Krka 5 mg film-coated tablets
PA1347/031/002
BISOPROLOL FUMARATE KRKA, d.d., Novo mesto Marketed
Candesartan Hydrochlorothiazide Krka 16mg/12.5mg tablets
PA1347/011/002
Candesartan cilexetil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Candesartan Hydrochlorothiazide Krka 32mg/12.5mg tablets
PA1347/011/003
Candesartan cilexetil, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Candesartan Hydrochlorothiazide Krka 32mg/25mg Tablets
PA1347/011/004
Candesartan cilexetil, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Candesartan Hydrochlorothiazide Krka 8mg/12.5mg tablets
PA1347/011/001
Candesartan cilexetil, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Candesartan Krka 16 mg tablets
PA1347/026/003
Candesartan cilexetil KRKA, d.d., Novo mesto Marketed
Candesartan Krka 32 mg Tablets
PA1347/026/004
Candesartan cilexetil KRKA, d.d., Novo mesto Not marketed
Candesartan Krka 4 mg tablets
PA1347/026/001
Candesartan cilexetil KRKA, d.d., Novo mesto Marketed
Candesartan Krka 8 mg tablets
PA1347/026/002
Candesartan cilexetil KRKA, d.d., Novo mesto Marketed
Carvedilol Krka 12.5 mg Tablets
PA1347/037/003
Carvedilol KRKA, d.d., Novo mesto Marketed
Carvedilol Krka 25 mg Tablets
PA1347/037/004
Carvedilol KRKA, d.d., Novo mesto Marketed
Carvedilol Krka 3.125 mg Tablets
PA1347/037/001
Carvedilol KRKA, d.d., Novo mesto Marketed
Carvedilol Krka 6.25 mg tablets
PA1347/037/002
Carvedilol KRKA, d.d., Novo mesto Marketed
Celecoxib Krka 100 mg capsules, hard
PA1347/033/001
Celecoxib KRKA, d.d., Novo mesto Marketed
1 2 3 4

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.